VF
SPRY icon

Virtu Financial’s ARS Pharmaceuticals SPRY Stock Holding History

Virtu Financial’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,201
Closed -$206K – 1849
2024
Q1 		$206K Buy
+20,201
New +$151K 0.02% 776
2023
Q4 		– Sell
-80,816
Closed -$305K – 1973
2023
Q3 		$305K Buy
+80,816
New +$530K 0.03% 500
2023
Q2 		– Sell
-10,411
Closed -$68K – 2003
2023
Q1 		$68K Buy
+10,411
New +$80K 0.01% 1051
2022
Q1 		– Sell
-20,317
Closed -$135K – 2002
2021
Q4 		$135K Buy
+20,317
New +$165K 0.01% 998

Other funds holding SPRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's SPRY Position: Q2 2024 in Review

Virtu Financial sold out of ARS Pharmaceuticals (SPRY) in Q2 2024, closing a stake of 20,201 shares — an estimated $206K sold.

Virtu Financial first reported a position in SPRY in Q4 2021 and held it in 4 quarters. The position peaked at $305K in Q3 2023. 115 funds tracked by Wall St. Rank hold SPRY as of Q2 2024.

  • Virtu Financial reported no remaining ARS Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 20,201 ARS Pharmaceuticals shares in Q2 2024, an estimated $206K.
  • Virtu Financial first reported a position in ARS Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Virtu Financial's ARS Pharmaceuticals position peaked at $305K in Q3 2023.
  • 115 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.